Identification and Biosynthesis of N1,N9-Bis(Glutathionyl)Aminopropylcadaverine (Homotrypanothione) in Trypanosoma Cruzi

Authors

  • Karl J. Hunter,

    1. Parasite and Vector Biochemistry Unit, Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, England
    Search for more papers by this author
  • Sarah A. Le Quesne,

    1. Parasite and Vector Biochemistry Unit, Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, England
    Search for more papers by this author
  • Alan H. Fairlamb

    Corresponding author
    1. Parasite and Vector Biochemistry Unit, Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, England
    Search for more papers by this author

A. H. Fairlamb, Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, Keppel St, London, WCIE 7HT, England

Abstract

Radiolabelling studies using tritiated omithine, arginine and lysine, together with the relevant amino acid decarboxylase enzyme assays, indicate that the epimastigote stage of Trypanosoma cruzi is unable to synthesise significant amounts of putrescine and cadaverine de novo, compared to the amounts of these diamines scavenged from the growth medium. Radiolabelled putrescine is readily incorporated into spermidine, spennine and the trypanosomatid-specific polyamine-glutathione conjugate trypanothione (N1, N8-bis(glutathionyl)spermidine). Likewise, radiolabelled cadaverine is incorporated into the analogous polyamines aminopropylcadaverine, bis(aminopropyl)cadaverine and another major unidentified component. Subsequent studies showed this major component to be a novel polyamine-thiol conjugate whose structure was confirmed by chemical synthesis to be N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione). Kinetic analyses using recombinant T. cruzi trypanothione reductase demonstrated that homotrypanothione disulphide is readily reduced by this enzyme with kinetic parameters similar to trypanothione disulphide, suggesting that it is a physiological substrate in vivo. Thus the epimastigote form of T. cruzi differs significantly from the African trypanosomes and Leishmania in (a) being unable to synthesise significant amounts of diamines de novo, (b) converting significant amounts of putrescine and cadaverine to spermine and bis(aminopropyl)cadaverine, respectively and (c) the ability to synthesise homotrypanothione as well as trypanothione. The implications of these findings with respect to the prospective chemotherapy of Chagas’ disease are discussed.

Ancillary